AAAAAA
Results:
1-22
|
Results: 22
Authors:
Szalai, C
Kozma, GT
Nagy, A
Bojszko, A
Krikovszky, D
Szabo, T
Falus, A
Citation: C. Szalai et al., Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity, J ALLERG CL, 108(3), 2001, pp. 375-381
Authors:
Szalai, C
Duba, J
Prohaszka, Z
Kalina, A
Szabo, T
Nagy, B
Horvath, L
Csaszar, A
Citation: C. Szalai et al., Involvement of polymorphisms in the chemokine system in the susceptibilityfor coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1-2518 G/G genotype in CAD patients, ATHEROSCLER, 158(1), 2001, pp. 233-239
Authors:
Kalina, A
Csaszar, A
Czeizel, AE
Romics, L
Szaboki, F
Szalai, C
Reiber, I
Nemeth, A
Stephenson, S
Williams, RR
Citation: A. Kalina et al., Frequency of the R3500Q mutation of the apolipoprotein B-100 gene in a sample screened clinically for familial hypercholesterolemia in Hungary, ATHEROSCLER, 154(1), 2001, pp. 247-251
Authors:
Kalina, A
Csaszar, A
Fust, G
Nagy, B
Szalai, C
Karadi, I
Duba, J
Prohaszka, Z
Horvath, L
Dieplinger, H
Citation: A. Kalina et al., The association of serum lipoprotein(a) levels, apolipoprotein(a) size and(TTTTA)(n) polymorphism with coronary heart disease, CLIN CHIM A, 309(1), 2001, pp. 45-51
Authors:
Molnar, EL
Hegyesi, H
Toth, S
Darvas, Z
Laszlo, V
Szalai, C
Falus, A
Citation: El. Molnar et al., Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, isregulated by melanoma-derived histamine, SEM CANC B, 10(1), 2000, pp. 25-28
Authors:
Radvany, Z
Darvas, Z
Kerekes, K
Prechl, J
Szalai, C
Pallinger, E
Valeria, L
Varga, AL
Sandor, M
Erdei, A
Falus, A
Citation: Z. Radvany et al., H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells, SEM CANC B, 10(1), 2000, pp. 41-45
Authors:
Heninger, E
Falus, A
Darvas, Z
Szalai, C
Zsinko, M
Pos, Z
Hegyesi, H
Citation: E. Heninger et al., Both interferon (IFN)alpha and IFN gamma inhibit histidine decarboxylase expression in the HT168 human melanoma cell line, INFLAMM RES, 49(8), 2000, pp. 393-397
Authors:
Horvath, B
Heninger, E
Hegyesi, H
Lazar, E
Radvany, Z
Szalai, C
Darvas, Z
Falus, A
Citation: B. Horvath et al., Reciprocal inhibitory interactions between interferon gamma and histamine in melanoma, INFLAMM RES, 49, 2000, pp. S27-S28
Authors:
Kaczur, V
Takacs, M
Szalai, C
Falus, A
Nagy, Z
Berencsi, G
Balazs, C
Citation: V. Kaczur et al., Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease, EUR J IMM, 27(1), 2000, pp. 17-23
Authors:
Szalai, C
Toth, S
Falus, A
Citation: C. Szalai et al., Exon-intron organization of the human gp130 gene, GENE, 243(1-2), 2000, pp. 161-166
Authors:
Szalai, C
Czinner, A
Csaszar, A
Citation: C. Szalai et al., Influence of apolipoprotein E genotypes on serum lipid parameters in a biracial sample of children, EUR J PED, 159(4), 2000, pp. 257-260
Authors:
Igaz, P
Horvath, A
Horvath, B
Szalai, C
Pallinger, E
Rajnavolgyi, E
Toth, S
Rose-John, S
Falus, A
Citation: P. Igaz et al., Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production, IMMUNOL LET, 71(3), 2000, pp. 143-148
Authors:
Szalai, C
Bojszko, A
Beko, G
Falus, A
Citation: C. Szalai et al., Prevalence of CCR5 Delta 32 in allergic diseases, LANCET, 355(9197), 2000, pp. 66-66
Authors:
Haak-Frendscho, M
Darvas, Z
Hegyesi, H
Karpati, S
Hoffman, RL
Laszlo, V
Bencsath, M
Szalai, C
Furesz, J
Timar, J
Bata-Csorgo, Z
Szabad, G
Pivarcsi, A
Pallinger, E
Kemeny, L
Horvath, A
Dobozy, A
Falus, A
Citation: M. Haak-frendscho et al., Histidine decarboxylase expression in human melanoma, J INVES DER, 115(3), 2000, pp. 345-352
Authors:
Szombathy, T
Janoskuti, L
Szalai, C
Csaszar, A
Miklosi, M
Meszaros, Z
Kempler, P
Laszlo, Z
Fenyvesi, T
Romics, L
Citation: T. Szombathy et al., Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapsesyndrome, AM HEART J, 139(1), 2000, pp. 101-105
Authors:
Szalai, S
Szalai, C
Becker, K
Torok, E
Citation: S. Szalai et al., Keratin 9 mutations in the coil 1A region in epidermolytic palmoplantar keratoderma, PEDIAT DERM, 16(6), 1999, pp. 430-435
Authors:
Horvath, BV
Szalai, C
Mandi, Y
Laszlo, V
Radvany, Z
Darvas, Z
Falus, A
Citation: Bv. Horvath et al., Histamine and histamine-receptor antagonists modify gene expression and biosynthesis of interferon gamma in peripheral human blood mononuclear cells and in CD19-depleted cell subsets, IMMUNOL LET, 70(2), 1999, pp. 95-99
Authors:
Holub, MC
Szalai, C
Polgar, A
Toth, S
Falus, A
Citation: Mc. Holub et al., Generation of 'truncated' interleukin-6 receptor (IL-6R) mRNA by alternative splicing; a possible source of soluble IL-6R, IMMUNOL LET, 68(1), 1999, pp. 121-124
Authors:
Hegyesi, H
Szalai, C
Falus, A
Csaba, G
Citation: H. Hegyesi et al., The histidine decarboxylase (HDC) gene of tetrahymena pyriformis is similar to the mammalian one. A study of HDC expression, BIOSCI REP, 19(2), 1999, pp. 73-79
Authors:
Szalai, C
Csaszar, A
Czinner, A
Szabo, T
Panczel, P
Madacsy, L
Falus, A
Citation: C. Szalai et al., Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus, PEDIAT RES, 46(1), 1999, pp. 82-84
Authors:
Szalai, C
Csaszar, A
Czinner, A
Palicz, T
Halmos, B
Romics, L
Citation: C. Szalai et al., Genetic investigation of patients with hypercholesterolemia type IIa, CLIN GENET, 55(1), 1999, pp. 67-68
Authors:
Holub, MC
Mako, E
Devay, T
Dank, M
Szalai, C
Fenyvesi, A
Falus, A
Citation: Mc. Holub et al., Increased interleukin-6 levels, interleukin-6 receptor and gp130 expression in peripheral lymphocytes of patients with inflammatory bowel disease, SC J GASTR, 33, 1998, pp. 47-50
Risultati:
1-22
|